FDA Adverse Event Malfunction Summary report: N

OMNIPOD INSULIN MANAGEMENT SYSTEM

MDR report key: 12174313 · Received July 15, 2021

Report

Report Number
3004464228-2021-11785
Event Type
Malfunction
Date Received
July 15, 2021
Date of Event
May 22, 2021
Report Date
July 13, 2021
Manufacturer
INSULET CORPORATION
Product Code
LZG
UDI-DI
20385081120033
PMA / PMN Number
K192659
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

NO BENDS OR KINKS WERE OBSERVED ON THE SOFT CANNULA. FLUID WAS SUCCESSFULLY ABLE TO PASS THROUGH THE ENTIRE FLUID PATH AND OUT THE DISTAL TIP OF THE SOFT CANNULA. A LEAK TEST WAS PERFORMED AND NO LEAKAGES WERE OBSERVED. THE DEVICE WAS RECEIVED WITH THE ADHESIVE PAD ATTACHED TO THE BOTTOM HOUSING. THE ADHESIVE PAD WELDS WERE OBSERVED TO BE INCORRECTLY INSTALLED. THIS DID NOT AFFECT INSULIN DELIVERY.

Additional Manufacturer Narrative · 1

THE DEVICE HAS NOT BEEN RETURNED/RECEIVED TO DATE. IF THE DEVICE IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED WITH THE INVESTIGATION RESULTS. WE ARE UNABLE TO CONFIRM THE BENT CANNULA OR TO DETERMINE IF IT COULD HAVE CONTRIBUTED TO THE REPORTED HYPERGLYCEMIA. LOT RELEASE RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. SPECIFICALLY, A POD IS PAIRED TO A PDM AND PUT THROUGH SIMULATED USE TESTING INCLUDING CONFIRMING THE BLUE SOFT CANNULA IS INSPECTED FOR ANY DAMAGE.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT'S BLOOD GLUCOSE LEVELS REACHED 400 MG/DL WHILE WEARING THE POD BETWEEN 36 AND 48 HOURS. WHEN REMOVED FROM THE INFUSION SITE (ABDOMEN), THE POD'S CANNULA WAS FOUND BENT. "LIGHT" KETONES WERE ALSO PRESENT. AS TREATMENT, A MANUAL INJECTION OF INSULIN WAS DELIVERED AND A NEW POD WAS APPLIED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1069698 OMNIPOD INSULIN MANAGEMENT SYSTEM PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 19191 L72232 20385081120033

Patients

Seq Age Sex Outcome Treatment
1 15 YR